Concepedia
Statistics
Publications
8
Citations
354
H-Index
Active since
2014
Affiliations
Bose Institute(Current)
Institute of Post Graduate Medical Education and Research
Bankura Sammilani Medical College
KIIT University
Kirti Kajal is an author at Bose Institute specializing in oncology, medicine, and regulatory t cells.
Publications per year
2014–2021
Aspirin Suppresses the Acquisition of Chemoresistance in Breast Cancer by Disrupting an NFκB–IL6 Signaling Axis Responsible for the Generation of Cancer Stem Cells
Shilpi Saha, Shravanti Mukherjee, Poulami Khan et al. · Cancer Research · 2016 · 110 citations
Medicine, Oncology, Pharmacology +17
Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells
Sreeparna Chakraborty, Abir K. Panda, Sayantan Bose et al. · Scientific Reports · 2017 · 53 citations · Full text
Life Sciences, Immunology, Oncology +13
Mithramycin A sensitizes therapy-resistant breast cancer stem cells toward genotoxic drug doxorubicin
Shilpi Saha, Shravanti Mukherjee, Minakshi Mazumdar et al. · Translational research · 2014 · 49 citations
Medicine, Oncology, Pharmacology +12
<scp>MEK</scp> inhibition prevents tumour‐shed transforming growth factor‐<i>β</i>‐induced T‐regulatory cell augmentation in tumour milieu
Dewan Md Sakib Hossain, Abir K. Panda, Sreeparna Chakrabarty et al. · Immunology · 2014 · 44 citations · Full text
Medicine, Immunology, Oncology +17
Andrographolide binds to ATP-binding pocket of VEGFR2 to impede VEGFA-mediated tumor-angiogenesis
Kirti Kajal, Abir K. Panda, Jyotsna Bhat et al. · Scientific Reports · 2019 · 40 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +14
1–5 of 8